INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report

Oct 16, 2024

TORONTO, October 16, 2024 | INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to share their latest report titled, ‘Unlocking Medtech’s Potential: Canada’s Strategic Advantages in Image-Guided Therapy & AI’. Through synthesized insights from interviews with founders and executives from 30 IGT companies in the INOVAIT Network, this new report uncovers the untapped potential of the image-guided therapy sector in Canada.

Image-guided therapy encompasses groundbreaking technologies that integrate medical imaging techniques to enhance the full spectrum of patient care from diagnostic interventions to treatment planning and execution, and post-treatment evaluation. This innovative healthcare route, championed by Sunnybrook Research Institute, is gaining traction in healthcare due to its significant improvements in patient outcomes, provider experience, and cost-effectiveness.

Key Findings: The Benefits of Building an IGT Company in Canada

The report highlights several strategic benefits identified by industry leaders for founding and operating their companies in Canada, including:

  • Research Excellence: A strong academic and research foundation fostering innovation in IGT.
  • Deep Talent Pool: Access to a skilled workforce in medicine, engineering, and technology, including world-leading specialists in AI.
  • Global Access: Opportunities for international collaboration and a geography and policy landscape enabling preferred market expansion.
  • Non-dilutive Capital: Availability of funding sources including those from government that do not require relinquishing equity.
  • Capital Efficiency: An environment conducive to developing cost-effective businesses and technologies.
  • Supportive Community: A collaborative network that promotes resource-sharing and knowledge exchange.

Overall, this report emphasizes that Canada possesses unique advantages to fortify a global stronghold in IGT innovation.

As the global medtech landscape continues to evolve, this report serves as a landmark resource for stakeholders seeking to understand the unique benefits of Canada’s IGT sector. By capturing the authentic voices of Canadian industry leaders, INOVAIT showcases not only the potential of Canadian companies but also the collaborative spirit driving advancements and commercialization in healthcare technology.

You can review the full report here: www.inovait.ca/reports

Partagez ceci sur les réseaux sociaux

En savoir plus sur nous

INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care

INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care

Les membres du secteur du réseau INOVAIT mettent au point des technologies d’IA qui révolutionnent le diagnostic et le traitement des maladies et améliorent les résultats pour les patients tout en consolidant l’économie canadienne de la santé. Les données de santé dont ces entreprises ont besoin pour créer leurs technologies sont le plus souvent détenues par des établissements de soins de santé canadiens qui sont réticents à communiquer des données à des partenaires commerciaux en raison d’un manque de clarté de la législation sur la protection de la vie privée et de pratiques antérieures axées principalement sur l’atténuation des risques en matière de sécurité et de protection de la vie privée.